Table 1.
Groups | Median survival time (day) | Lifetime prolonging rate (%) |
---|---|---|
MG | 35.83 ± 15.64 | – |
CTX | 53.13 ± 9.38** | 48.26 ± 26.11 |
HA-H | 46.85 ± 15.09 | 27.97 ± 42.12 |
HA-L | 47.14 ± 8.30 | 31.56 ± 23.15 |
CG | 57.00 ± 8.57** | 59.07 ± 23.91 |
MG: model vehicle control group; CTX: CTX-treated group; HA-H: high-dose helvolic acid; HA-L: low-dose helvolic acid; CG: combination of CTX + HA-L group. **P < 0.01 vs. MG, n = 8.